Aplindore
- Generic Name
- Aplindore
- Brand Names
- -
- Drug Type
- Small Molecule
- Chemical Formula
- C18H18N2O3
- CAS Number
- 189681-70-7
- Unique Ingredient Identifier
- Q5O76TA0ML
- Indication
Investigated for use/treatment in parkinson's disease and neurologic disorders.
- Associated Conditions
- -
- Associated Therapies
- -
The Effects of Aplindore on the Treatment of Signs and Symptoms of Restless Legs Syndrome
- First Posted Date
- 2008-02-29
- Last Posted Date
- 2011-10-03
- Lead Sponsor
- Ligand Pharmaceuticals
- Target Recruit Count
- 24
- Registration Number
- NCT00626418
- Locations
- 🇺🇸
MD Clinical, Hallandale Beach, Florida, United States
🇺🇸Clinilabs, Inc., New York, New York, United States
🇺🇸Sleep Disorders Center of Georgia, Atlanta, Georgia, United States
The Effects of Aplindore on the Treatment of Signs and Symptoms of Parkinson's Disease
- First Posted Date
- 2008-02-26
- Last Posted Date
- 2011-10-03
- Lead Sponsor
- Ligand Pharmaceuticals
- Target Recruit Count
- 40
- Registration Number
- NCT00623324
- Locations
- 🇺🇸
Miami Research Associates, Miami, Florida, United States
Drug Development Updates
Stay informed with timely notifications on clinical trials, regulatory changes, and research advancements related to this medication.
© Copyright 2024. All Rights Reserved by MedPath